This list is an analysis based on recent market events. It's not an investment recommendation.
About
Sakar Healthcare Limited, founded in 2004 and based in Ahmedabad, India, is a pharmaceutical company actively involved in the full spectrum of drug development, from research and manufacturing to marketing its products. The company's diverse product line includes liquid oral medications, cephalosporin-based drugs (available as tablets, capsules, and dry powder syrups), various injectable forms such as dry powder injections, and liquid injectable solutions (supplied in ampoules, vials, and lyophilized preparations), alongside oral solid dosages. Their comprehensive portfolio addresses approximately 22 distinct therapeutic categories, encompassing treatments for conditions like acidity, malaria, blood clotting, constipation, respiratory issues, pain, infections, depression, allergies, and nutritional deficiencies, among others. Sakar Healthcare also has a significant global reach, distributing its products to roughly 38 countries across regions including Southeast Asia, other parts of Asia, both English and French-speaking African nations, the Middle East and North Africa, and the United States.
Depending on the exchange, the stock ticker may vary. For instance, on NSE (India) exchange Sakar Healthcare stocks are traded under the ticker SMSAKAR.NSE.
What is Sakar Healthcare revenue for the last year?▼
Sakar Healthcare revenue for the last year amounts to 3.62B INR.
What is Sakar Healthcare net income for the last year?▼
SMSAKAR.NSE net income for the last year is 396.96M INR.
How many employees does Sakar Healthcare have?▼
As of September 04, 2026, the company has 325 employees.
In which sector is Sakar Healthcare located?▼
Sakar Healthcare operates in the Health & Wellness sector.
When did Sakar Healthcare complete a stock split?▼
Sakar Healthcare has not had any recent stock splits.
Where is Sakar Healthcare headquartered?▼
Sakar Healthcare is headquartered in Ahmedabad, India.